Pulse Biosciences, Inc. Profile
Industry
Medical - Instruments & SuppliesSector
HealthcareNumber of Employees
61Pulse Biosciences's Business Model
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
About Pulse Biosciences
Website: https://www.pulsebiosciences.com
CEO (Chief Executive Officer): Mr. Robert W. Duggan
IPO date: 2016-05-18
Contact
Country: US
Address: 3957 Point Eden Way
City: Hayward
State: CA
Phone: 510 906 4600
Zip Code: 94545
Other
CIK: 0001625101
ISIN: US74587B1017
CUSIP: 74587B101
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
